7041 - 7050 of 9117 Results
Title
Year
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page: e376End Page: e389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 133
-
OPENTitle: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinationsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 519End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-28087-0Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/5fb2b0df-3d7e-4038-b91f-80c6299dc098Citation Count: 36
-
OPENTitle: Mitochondrial haplogroups and cognitive progression in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 1Start Page: 42End Page: 49Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awac327Best OA location URL: https://academic.oup.com/brain/article-pdf/146/1/42/50417168/awac327.pdfCitation Count: 24
-
OPENTitle: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 1Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000521232Best OA location URL: https://www.karger.com/Article/Pdf/521232Citation Count: 16
-
OPENTitle: Need for personalized monitoring of Parkinson’s disease: the perspectives of patients and specialized healthcare providersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1150634End Page: 1150634Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1150634Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1150634/pdfCitation Count: 28
-
OPENTitle: Golgi-IP, a tool for multimodal analysis of Golgi molecular contentJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 120Issue #: 20Start Page: e2219953120End Page: e2219953120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2219953120Best OA location URL: https://doi.org/10.1073/pnas.2219953120Citation Count: 67
-
OPENTitle: Activation mechanism of PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 602Issue #: 7896Start Page: 328End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-021-04340-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8828467Citation Count: 201
-
OPENTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://www.nature.com/articles/s41593-021-00999-y.pdfCitation Count: 612
-
OPENTitle: Assortative mixing in micro-architecturally annotated brain connectomesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38585-4Best OA location URL: https://www.nature.com/articles/s41467-023-38585-4.pdfCitation Count: 41
-
OPENTitle: Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s diseaseJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 32Issue #: 11Start Page: 1888End Page: 1900Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddad025Best OA location URL: https://pub.dzne.de/record/258096Citation Count: 17